| Model Number |
CMCV-124-LRG |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Seroma (2069)
|
| Date of Event |
05/06/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Notification was received from boston scientific sales representative that a 55 yr.Old male patient was implanted with a medtronic biventricular crt-d generator on (b)(6) 2026 using an elupro antibiotic-eluting bioenvelope (cmcv-124-lrg; lot #m26d1100).It was reported that the patient had developed a small seroma - specific date and specific course of treatment is unknown.The physician states that the reported seroma is related to the elupro bioenvelope and not procedure related.The elupro device remains implanted and no further details are available regarding the reported event, should any additional information be received, a follow-up report will be submitted.
|
| |
|
Additional Manufacturer Narrative
|
|
Manufacturing review of the elupro antibiotic-eluting bioenvelope device history record was completed resulting in no quality issues identified during processing of the final packaging, or the sterile subassembly manufacturing lots.It is noted that per the instructions for use (ifu - art-20837 rev.A, ifu elupro antibiotic-eluting bioenvelope) provided with each finished elupro device, that "seroma" is a potential known complication associated with the use of the elupro bioenvelope or any cardiac surgical implant procedure.The information provided by the reporting physician states the reported seroma as being a result of the usage of the elupro bioenvelope device.No other details are available, should any additional information be received a follow up report will be filed.
|
| |
|
Search Alerts/Recalls
|